TEVIMBRA

NDC 72579-125 · BeOne Medicines USA, Inc.

Generic nametislelizumab-jsgr

Dosage formINJECTION, SOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)TISLELIZUMAB

Strength10 mg/mL

Pharmacologic classProgrammed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Marketing categoryBLA

Packages

72579-125-00 — 1 VIAL, GLASS in 1 CARTON (72579-125-00) / 15 mL in 1 VIAL, GLASS

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.